- Home
- GSK vs MDLZ Comparison
GSK vs MDLZ Comparison
Compare GSK & MDLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GSK | MDLZ |
|---|---|---|
| Founded | 1715 | 2000 |
| Country | United Kingdom | United States |
| Employees | 66841 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7B | 79.3B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | GSK | MDLZ |
|---|---|---|
| Price | $52.02 | $61.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 20 |
| Target Price | N/A | ★ $66.95 |
| AVG Volume (30 Days) | 3.9M | ★ 8.2M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.40% | 3.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $38,537,000,000.00 |
| Revenue This Year | $6.99 | $4.83 |
| Revenue Next Year | $4.19 | $3.10 |
| P/E Ratio | ★ $32.75 | $135.25 |
| Revenue Growth | N/A | ★ 5.75 |
| 52 Week Low | $35.45 | $51.20 |
| 52 Week High | $61.70 | $71.15 |
Technical Indicators
Market Signals| Indicator | GSK | MDLZ |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 48.75 |
| Support Level | $51.55 | $60.47 |
| Resistance Level | $53.45 | $62.60 |
| Average True Range (ATR) | 0.82 | 1.39 |
| MACD | 0.11 | -0.32 |
| Stochastic Oscillator | 64.29 | 32.96 |
Price Performance
Historical ComparisonAbout GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About MDLZ Mondelez International Inc.
Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack enclave with a presence in the biscuit (48% of sales as of the end of fiscal 2025), chocolate (33%), gum/candy (10%), beverage (3%), and cheese and grocery (6%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm derives around one-third of its revenue from developing markets, around 40% from Europe, and more than one-fourth from North America.